✨ Free AI Report
Vital KSK Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Vital KSK Holdings, Inc.
Company Research

Vital KSK Holdings, Inc.: Business Overview, Financials & Competitive Analysis

Vital KSK Holdings, Inc. scores 6/10 on the AskCyborg Cyborg Score (Solid). Defensive, dividend-yielding pharmaceutical distributor with undervalued metrics and stable operations, suitable for income-focused investors. Vital KSK demonstrates solid fundamentals with a strong balance sheet, attractive valuation, and stable dividend yield. However, the company faces modest growth momentum and corporate governance concerns, with limited board independence constraining investment appeal.

What is Vital KSK Holdings, Inc.'s industry? Vital KSK Holdings, Inc. (vitalksk.co.jp) operates in Pharmaceutical Wholesale Distribution & Healthcare Services. AskCyborg classifies Vital KSK Holdings, Inc. under Pharmaceutical Wholesale Distribution & Healthcare Services in its company registry.

Vital KSK Holdings engages in the wholesale and retail sale of pharmaceutical products in Japan, with diversified operations across nursing care, agrochemical wholesale, veterinary drug wholesale, and medical and phar...

6/ 10Solid

Cyborg Score thesis

Defensive, dividend-yielding pharmaceutical distributor with undervalued metrics and stable operations, suitable for...

Read the full analyst-debate transcript →
Industry Pharmaceutical Wholesale Distribution & Healthcare Services
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Vital KSK Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Vital KSK Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for Vital KSK Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Vital KSK Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Vital KSK Holdings, Inc. Overview

Pro stress-test →

Vital KSK Holdings engages in the wholesale and retail sale of pharmaceutical products in Japan, with diversified operations across nursing care, agrochemical wholesale, veterinary drug wholesale, and medical and pharmacy consulting businesses. The company also provides property & casualty insurance services and elderly care services through subsidiaries.

Strategic Profile

Pro stress-test →

Incorporated in 2009 and headquartered in Setagaya, Japan, Vital KSK operates as a diversified healthcare and pharmaceutical distribution player in the Japanese market. The company maintains a stable operational profile with a market cap of approximately ¥61.985B and a P/E ratio of 8.73, indicating attractive valuation multiples for dividend-focused investors.

Competitive Landscape

Pro stress-test →

Vital KSK competes within Japan's pharmaceutical wholesale and distribution sector against major players like Suzuken, Toho Holdings, and WIN-Partners. The company differentiates through its integrated service model combining wholesale distribution with consulting, nursing care, and insurance services, serving hospitals, pharmacies, and medical institutions across Japan.

Industry Context

Vital KSK Holdings, Inc. operates in Pharmaceutical Wholesale Distribution & Healthcare Services.

Key facts

Founded: 2009 · Headquarters: Setagaya, Tokyo, Japan · Employees: 3,705 · Market cap: ¥61.985B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Vital KSK Holdings, Inc..

  • Strong dividend profile with 3.76% yield, appealing to risk-averse Japanese investors
  • Trading at significant discount to fair value with low P/E multiple of 8.73x
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • March 2026Stock trading at ¥1,219-1,399 JPY with modest volatility
  • 2025Market cap approximately ¥61.985B with earnings scheduled for August reporting
  • +1 moreTrack every material event for Vital KSK Holdings, Inc. as it happens. Explore monitoring →
Get alerted when Vital KSK Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Pharmaceutical Wholesale & DistributionJapan's largest pharmaceutical distributor→Medical DistributionDiversified pharmaceutical and medical equipment distributor→Healthcare ServicesIntegrated pharmaceutical distribution and consulting→

Compare Vital KSK Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Vital KSK Holdings, Inc. operates in Pharmaceutical Wholesale Distribution & Healthcare Services. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Wholesale Distribution & Healthcare Services research →
NEW · MCP server

Ask your AI assistant about Vital KSK Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Vital KSK Holdings, Inc. and its top competitor on Cyborg Score”
“What did Vital KSK Holdings, Inc. do this quarter?”
“Is Vital KSK Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Vital KSK Holdings, Inc. do?+
Vital KSK Holdings engages in the wholesale and retail sale of pharmaceutical products in Japan, with diversified operations across nursing care, agrochemical wholesale, veterinary drug wholesale, and medical and phar...
What is Vital KSK Holdings, Inc.'s Cyborg Score?+
Vital KSK Holdings, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Vital KSK Holdings, Inc.'s main competitors?+
Named competitors include Pharmaceutical Wholesale & Distribution, Medical Distribution, Healthcare Services. The full competitive landscape is in the AskCyborg report.
How can I get the full Vital KSK Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Vital KSK Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Vital KSK Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.